Whilst Y132F strongly associated with high fluconazole MICs; commonly reported ~16–≥64-fold increases in MIC (typical MICs reported in resistant isolates: ≥64 → >128 µg/mL in many studies).
Often raises voriconazole MICs 4–16-fold with reported MICs in resistant isolates of ~1–8 µg/mL (varies). Y132F reduces azole binding affinity in the active site.
Widely reported in clinical isolates worldwide (outbreaks and surveillance collections). Frequently seen in combination with efflux upregulation or other ERG11 substitutions (common in C. albicans and other Candida spp.).
Comments
Post a Comment